Children with a new diagnosis of acute lymphoblastic leukaemia who receive intensified central nervous system-directed therapy have an increased risk of neurocognitive deficits, indicates research published in the Journal of Clinical Oncology.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.